Name
Toca 511
Alternate Names
Toca FC
Abbreviations
None
Category
Biologic therapy (BRM, immunotherapy)
Subcategory
None
NSC Number
None
Primary Site
Brain
Histology
Glioblastoma, anaplastic astrocytoma
Remarks
July 19, 2015: U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Toca 511 & Toca FC, for the treatment of recurrent high grade glioma, which includes glioblastoma and anaplastic astrocytoma. This drug has not yet received final approval. code as Other Treatment and assign code 2.
Coding
Please see remarks for additional information
Home